Roman Groisberg

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Dna Methylation

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature reviews. Clinical oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Omar Alhalabi, Roman Groisberg, Ralph Zinner, Andrew W Hahn, Aung Naing, Shizhen Zhang, Apostolia-Maria Tsimberidou, Jordi Rodon, Siqing Fu, Timothy Anthony Yap, David S Hong, Ming Sun, Yunfang Jiang, Shubham Pant, Amishi Y Shah, Amado J Zurita, Nizar M Tannir, Raghunandan Vikram, Jason Roszik, Funda Meric-Bernstam, Vivek Subbiah
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies. NPJ precision oncology 7 (1) (2023)
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D Galsky, Erika Paige Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun-Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J Monk, Danny Nguyen, Do Youn Oh, Alicia F C Okines, David M O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cedric Van Marcke, Evan Y Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas Eldridge Stinchcombe, Tanios S Bekaii-Saab
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Janice M Mehnert, Tara C Mitchell, Alexander C Huang, Tomas S Aleman, Benjamin J Kim, Lynn M Schuchter, Gerald P Linette, Giorgos C Karakousis, Sheryl Mitnick, Lydia Giles, Mary Carberry, Noelle Frey, Andrew Kossenkov, Roman Groisberg, Leonel F Hernandez-Aya, George Ansstas, Ann W Silk, Sunandana Chandra, Jeffrey A Sosman, Phyllis A Gimotty, Rosemarie Mick, Ravi K Amaravadi
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Aakash Desai, Justin F Gainor, Aparna Hegde, Alison M Schram, Curigliano Giuseppe, Sumanta Pal, Stephen V Liu, Balazs Halmos, Roman Groisberg, Enrique Grande, Tomislav Dragovich, Marc Matrana, Neeraj Agarwal, Sant Chawla, Shumei Kato, Gilberto Morgan, Pashtoon Murtaza Kasi, Benjamin Solomon, Herbert H Loong, Haeseong Park, Toni K Choueiri, Ishwaria M Subbiah, Naveen Pemmaraju, Vivek Subbiah, null null
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Nature reviews. Clinical oncology 18 (5) (2021)
Roman Groisberg, Vivek Subbiah
Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Shang-Jui Wang, Karishma Khullar, Sinae Kim, Nikhil Yegya-Raman, Jyoti Malhotra, Roman Groisberg, Samuel H Crayton, Ann W Silk, John L Nosher, Michael A Gentile, Janice M Mehnert, Salma K Jabbour
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Roman Groisberg, Jason Roszik, Anthony P Conley, Alexander J F Lazar, Daniella E Portal, David S Hong, Aung Naing, Cynthia E Herzog, Neeta Somaiah, Maria Alejandra Zarzour, Shreyaskumar Patel, Robert E Brown, Vivek Subbiah
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies. Molecular cancer therapeutics 19 (5) (2020)
Jason Roszik, Abir Khan, Anthony P Conley, Jonathan A Livingston, Roman Groisberg, Vinod Ravi, Roberto Carmagnani Pestana, Shiraj Sen, Vivek Subbiah
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets. Cancers 11 (9) (2019)